EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
Kay W. Colston(St George's Hospital), R. Charles Coombes(Imperial College London), Alan Mackay(Institute of Cancer Research), Lise Binderup(Leo Pharma (Denmark)), Sharon Y. James(St George's Hospital), Surinder K. Chander(Charing Cross Hospital)
Cited by 226
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k